High-Quality Systemic Lupus Erythematosus CD19 B Cells for Immunology and Autoimmune Research

SLE CD19 B Cells are purified from peripheral blood of IRB-consented adult donors diagnosed with Systemic Lupus Erythematosus (SLE). These disease-relevant B lymphocytes support in-depth studies of immune dysregulation, autoantibody production, and chronic inflammation associated with SLE. Cryopreserved for optimal viability, these cells are ideal for translational research and therapeutic discovery.

Product Features

• Research Use Only (RUO), CD19+ B cells
• Isolated from SLE donors with confirmed clinical diagnosis
• High purity and viability
• Cryopreserved using CryoStore® CS10 media
• Processed within 24 hours of collection
• IRB-approved protocols and HIPAA-compliant handling

Donor Metadata

• Confirmed diagnosis of SLE
• Demographic data: age, sex assigned at birth, race/ethnicity
• Medication and clinical history available

Applications

• Disease-specific B cell profiling and immune phenotyping
• Autoantibody production and BCR signaling studies
• Autoimmune and chronic inflammatory disease modeling
• Biomarker discovery and therapeutic target validation

Compliance and Quality Assurance

• IRB-approved collections with 21 CFR Part 11–compliant e-consent
• Standardized processing and cryopreservation protocols
• HIPAA-compliant donor data protection

Ordering & Customization

Systemic Lupus Erythematosus B Cells are available in standard or custom aliquot sizes. For international shipping, documentation, or regulatory support, please contact [email protected].